Cure My Disease

Don't miss your cure!

 Log in / Sign up

New injectable treatment shows promise for schizophrenia relapse

NCT ID NCT05480046

Completed Disease control Sponsor: Rovi Pharmaceuticals Laboratories Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well Risperidone ISM works for people with schizophrenia who were hospitalized after a relapse. Researchers tracked 275 patients over 56 days to see if their symptoms improved and if they could better manage daily life. The treatment is given as an injection and aims to control the disease long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SCHIZOPHRENIA

Contacts and locations

Locations

  • Investigational Site number DE-01

    Essen, Germany

  • Investigational site number DE-02

    Chemnitz, Germany

  • Investigational site number DE-03

    Dortmund, Germany

  • Investigational site number DE-04

    Munich, Germany

  • Investigational site number DE-05

    Mannheim, Germany

  • Investigational site number DE-06

    Aachen, Germany

  • Investigational site number DE-07

    Bonn, Germany

  • Investigational site number DE-08

    Greifswald, Germany

  • Investigational site number DE-09

    München, Germany

  • Investigational site number DE-10

    Berlin, Germany

  • Investigational site number DE-12

    Berlin, Germany

  • Investigational site number DE-13

    Werneck, Germany

  • Investigational site number DE-14

    Ansbach, Germany

  • Investigational site number DE-15

    Berlin, Germany

  • Investigational site number DE-16

    Bonn, Germany

  • Investigational site number DE-19

    Leipzig, Germany

  • Investigational site number DE-20

    Hemer, Germany

  • Investigational site number DE-22

    Hamburg, Germany

  • Investigational site number DE-23

    Bayreuth, Germany

  • Investigational site number DE-24

    Neustadt, Germany

  • Investigational site number DE-25

    Eberswalde, Germany

  • Investigational site number ES-02

    Talavera de la Reina, Spain

  • Investigational site number ES-03

    Barcelona, Spain

  • Investigational site number ES-04

    Manacor, Spain

  • Investigational site number ES-11

    Granada, Spain

  • Investigational site number ES-14

    Móstoles, Spain

  • Investigational site number ES-16

    Burgos, Spain

  • Investigational site number ES-18

    Murcia, Spain

  • Investigational site number ES-19

    Madrid, Spain

  • Investigational site number ES-21

    Jaén, Spain

  • Investigational site number ES-23

    Córdoba, Spain

  • Investigational site number ES-24

    Madrid, Spain

  • Investigational site number ES-31

    Vigo, Spain

  • Investigational site number ES-40

    Vitoria-Gasteiz, Spain

  • Investigational site number ES-42

    Torrejón, Spain

  • Investigational site number ES-45

    Barcelona, Spain

  • Investigational site number ES-49

    Lleida, Spain

  • Investigational site number ES-51

    Lugo, Spain

  • Investigational site number ES-52

    Ourense, Spain

  • Investigational site number ES-59

    Huesca, Spain

  • Investigational site number ES-60

    Las Palmas de Gran Canaria, Spain

  • Investigational site number ES-62

    Ponferrada, Spain

  • Investigational site number ES-63

    Majadahonda, Spain

  • Investigational site number ES-65

    Mataró, Spain

  • Investigational site number ES-66

    Madrid, Spain

  • Investigational site number ES-69

    Santander, Spain

  • Investigational site number ES-70

    Jerez de la Frontera, Spain

  • Investigational site number ES-72

    L'Hospitalet de Llobregat, Spain

  • Investigational site number ES-73

    Manresa, Spain

  • Investigational site number ES-76

    Úbeda, Spain

  • Investigational site number ES-81

    Barcelona, Spain

  • Investigational site number GB-08

    London, United Kingdom

  • Investigational site number IT-03

    Legnano, Italy

  • Investigational site number IT-06

    Milan, Italy

  • Investigational site number IT-113

    Palermo, Italy

  • Investigational site number IT-18

    Montichiari, Italy

  • Investigational site number IT-19

    Bolzano, Italy

  • Investigational site number IT-20

    Crema, Italy

  • Investigational site number IT-24

    Brescia, Italy

  • Investigational site number IT-32

    Ancona, Italy

  • Investigational site number IT-41

    Foggia, Italy

  • Investigational site number IT-42

    Milan, Italy

  • Investigational site number IT-44

    Putignano, Italy

  • Investigational site number IT-47

    Manfredonia, Italy

  • Investigational site number IT-65

    Brindisi, Italy

  • Investigational site number IT-90

    Vimercate, Italy

  • Investigational site number IT-97

    Sant'Agata di Militello, Italy

  • Investigational site number PT-01

    Coimbra, Portugal

  • Investigational site number PT-11

    Santo Tirso, Portugal

  • Investigational site number PT-13

    Porto, Portugal

  • Investigational site number PT-20

    Guarda, Portugal

  • Investigational site number PT-24

    Braga, Portugal

  • Investigational site number PT-25

    Beja, Portugal

  • Investigational site number PT-27

    Tomar, Portugal

  • Investigational site number PT-32

    Portimão, Portugal

  • Investigational site number PT-33

    Funchal, Portugal

  • Investigational site number PT-36

    Funchal, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.